Literature DB >> 28755516

NOS1AP genetic variation is associated with impaired healing of diabetic foot ulcers and diminished response to healing of circulating stem/progenitor cells.

David J Margolis1, Michelle Hampton1, Ole Hoffstad1, D Scot Mala2, Ziad Mirza3, Diana Woltereck3, Steven Shannon2, Michael A Troiano2, Nandita Mitra4, Ming Yang5, Veena M Bhopale5, Stephen R Thom5.   

Abstract

It is unclear why many with diabetes develop foot ulcers (DFU) and why some do not heal. It could be associated with genetic variation. We have previously shown that NOS1AP variation is associated with lower extremity amputation in those with diabetes and that circulating stem progenitor cell concentration (SPC) is associated with impaired foot ulcer healing in those with diabetes. The goal of this study was to determine if NOS1AP variation is associated with impaired wound healing and with SPC mobilization in those with DFU. In longitudinal cohort study we demonstrate that NOS1AP variants rs16849113 and rs19649113 are associated with impaired wound healing and with SPC mobilization in those with DFU. We believe that further study of NOS1AP is merited and that it NOS1AP might be associated with a functional impairment.
© 2017 by the Wound Healing Society.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28755516      PMCID: PMC5747323          DOI: 10.1111/wrr.12564

Source DB:  PubMed          Journal:  Wound Repair Regen        ISSN: 1067-1927            Impact factor:   3.617


  15 in total

Review 1.  Effects of nitric oxide on stem cell therapy.

Authors:  Wuchen Wang; Yugyung Lee; Chi H Lee
Journal:  Biotechnol Adv       Date:  2015-09-21       Impact factor: 14.227

Review 2.  Epidemiology of foot ulceration and amputation: can global variation be explained?

Authors:  David J Margolis; William Jeffcoate
Journal:  Med Clin North Am       Date:  2013-04-25       Impact factor: 5.456

3.  Polymorphisms in the nitric oxide synthase 1 gene are associated with severe chronic rhinosinusitis.

Authors:  Yuan Zhang; Leandra Mfuna Endam; Abdelali Filali-Mouhim; Yohan Bossé; Roberto Castano; Martin Desrosiers
Journal:  Am J Rhinol Allergy       Date:  2011 Mar-Apr       Impact factor: 2.467

Review 4.  Nitric oxide in wound-healing.

Authors:  Jeff S Isenberg; Lisa A Ridnour; Michael Graham Espey; David A Wink; David D Roberts
Journal:  Microsurgery       Date:  2005       Impact factor: 2.425

5.  Common variation in the NOS1AP gene is associated with drug-induced QT prolongation and ventricular arrhythmia.

Authors:  Yalda Jamshidi; Ilja M Nolte; Chrysoula Dalageorgou; Dongling Zheng; Toby Johnson; Rachel Bastiaenen; Suzanne Ruddy; Daniel Talbott; Kris J Norris; Harold Snieder; Alfred L George; Vanessa Marshall; Saad Shakir; Prince J Kannankeril; Patricia B Munroe; A John Camm; Steve Jeffery; Dan M Roden; Elijah R Behr
Journal:  J Am Coll Cardiol       Date:  2012-06-06       Impact factor: 24.094

6.  NOS1AP Functionally Associates with YAP To Regulate Hippo Signaling.

Authors:  Leanne Clattenburg; Michael Wigerius; Jiansong Qi; Jan K Rainey; Jillian L Rourke; Shanmugam Muruganandan; Christopher J Sinal; James P Fawcett
Journal:  Mol Cell Biol       Date:  2015-04-27       Impact factor: 4.272

7.  Diabetes, lower extremity amputation, loss of protective sensation, and neuronal nitric oxide synthase associated protein in the chronic renal insufficiency cohort study.

Authors:  David J Margolis; Jayanta Gupta; Stephen R Thom; Raymond R Townsend; Peter A Kanetsky; Ole Hoffstad; Maryte Papdopoulos; Michael Fischer; Jeffrey R Schelling; Nandita Mitra
Journal:  Wound Repair Regen       Date:  2012-12-10       Impact factor: 3.617

8.  Association of genetic variants of NOS1AP with type 2 diabetes in a Chinese population.

Authors:  C Hu; C Wang; R Zhang; M C Ng; Y Bao; C Wang; W Y So; R C Ma; X Ma; J C Chan; K Xiang; W Jia
Journal:  Diabetologia       Date:  2009-11-24       Impact factor: 10.122

9.  Common variation in the NOS1AP gene is associated with reduced glucose-lowering effect and with increased mortality in users of sulfonylurea.

Authors:  Matthijs L Becker; Albert-Jan L H J Aarnoudse; Christopher Newton-Cheh; Albert Hofman; Jacqueline C M Witteman; André G Uitterlinden; Loes E Visser; Bruno H Ch Stricker
Journal:  Pharmacogenet Genomics       Date:  2008-07       Impact factor: 2.089

Review 10.  Mechanisms of NOS1AP action on NMDA receptor-nNOS signaling.

Authors:  Michael J Courtney; Li-Li Li; Yvonne Y Lai
Journal:  Front Cell Neurosci       Date:  2014-08-27       Impact factor: 5.505

View more
  5 in total

Review 1.  Role of growth factors and cytokines in diabetic foot ulcer healing: A detailed review.

Authors:  Mohammad Zubair; Jamal Ahmad
Journal:  Rev Endocr Metab Disord       Date:  2019-06       Impact factor: 6.514

2.  Further evidence that wound size and duration are strong prognostic markers of diabetic foot ulcer healing.

Authors:  David J Margolis; Nandita Mitra; D Scott Malay; Ziad K Mirza; John C Lantis; Hadar A Lev-Tov; Robert S Kirsner; Stephan R Thom
Journal:  Wound Repair Regen       Date:  2022-05-04       Impact factor: 3.401

3.  Differentiation of diabetic foot ulcer-derived induced pluripotent stem cells reveals distinct cellular and tissue phenotypes.

Authors:  Olga Kashpur; Avi Smith; Behzad Gerami-Naini; Anna G Maione; Rossella Calabrese; Ana Tellechea; Georgios Theocharidis; Liang Liang; Irena Pastar; Marjana Tomic-Canic; David Mooney; Aristidis Veves; Jonathan A Garlick
Journal:  FASEB J       Date:  2018-08-08       Impact factor: 5.191

4.  Translational development of ABCB5+ dermal mesenchymal stem cells for therapeutic induction of angiogenesis in non-healing diabetic foot ulcers.

Authors:  Andreas Kerstan; Kathrin Dieter; Elke Niebergall-Roth; Markus H Frank; Mark A Kluth; Sabrina Klingele; Michael Jünger; Christoph Hasslacher; Georg Daeschlein; Lutz Stemler; Ulrich Meyer-Pannwitt; Kristin Schubert; Gerhard Klausmann; Titus Raab; Matthias Goebeler; Korinna Kraft; Jasmina Esterlechner; Hannes M Schröder; Samar Sadeghi; Seda Ballikaya; Martin Gasser; Ana M Waaga-Gasser; George F Murphy; Dennis P Orgill; Natasha Y Frank; Christoph Ganss; Karin Scharffetter-Kochanek
Journal:  Stem Cell Res Ther       Date:  2022-09-05       Impact factor: 8.079

5.  Neutrophil microparticle production and inflammasome activation by hyperglycemia due to cytoskeletal instability.

Authors:  Stephen R Thom; Veena M Bhopale; Kevin Yu; Weiliang Huang; Maureen A Kane; David J Margolis
Journal:  J Biol Chem       Date:  2017-09-25       Impact factor: 5.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.